Cargando…

Tumor-Localized Administration of α-GalCer to Recruit Invariant Natural Killer T Cells and Enhance Their Antitumor Activity against Solid Tumors

Invariant natural killer T (iNKT) cells have the capacity to mount potent anti-tumor reactivity and have therefore become a focus in the development of cell-based immunotherapy. iNKT cells attack tumor cells using multiple mechanisms with a high efficacy; however, their clinical application has been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yan-Ruide, Zhou, Yang, Wilson, Matthew, Kramer, Adam, Hon, Ryan, Zhu, Yichen, Fang, Ying, Yang, Lili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317565/ https://www.ncbi.nlm.nih.gov/pubmed/35886891 http://dx.doi.org/10.3390/ijms23147547

Ejemplares similares

Synthesis of a 2''-Deoxy-β-GalCer
por: Thakur, Meena S., et al.
Publicado: (2014)

A Multifactorial Mechanism in the Superior Antimalarial Activity of α-C-GalCer
por: Schmieg, John, et al.
Publicado: (2010)

Interaction between Bacteria and the Immune System for Cancer Immunotherapy: The α-GalCer Alliance
por: Ustjanzew, Arsenij, et al.
Publicado: (2022)

α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials
por: Zhang, Yingting, et al.
Publicado: (2019)

Galactosylsphingamides: new α-GalCer analogues to probe the F’-pocket of CD1d
por: Guillaume, Joren, et al.
Publicado: (2017)

6″-Modifed α-GalCer-peptide conjugate vaccine candidates protect against liver-stage malaria
por: Meijlink, Michael A., et al.
Publicado: (2022)

Modulation of NKT cells and Th1/Th2 imbalance after α-GalCer treatment in progressive load-trained rats
por: Ru, Wang, et al.
Publicado: (2009)

Thermodynamic and Structural Behavior of α‐Galactosylceramide and C6‐Functionalized α‐GalCer in 2D Layers at the Air–Liquid Interface
por: Brezesinski, Gerald, et al.
Publicado: (2019)

Encapsulation of MERS antigen into α-GalCer-bearing-liposomes elicits stronger effector and memory immune responses in immunocompetent and leukopenic mice
por: Khan, Masood Alam, et al.
Publicado: (2022)

A Glycolipid α-GalCer Derivative, 7DW8-5 as a Novel Mucosal Adjuvant for the Split Inactivated Influenza Vaccine
por: Feng, Huapeng, et al.
Publicado: (2022)

Immunomodulatory Cell Therapy Using αGalCer-Pulsed Dendritic Cells Ameliorates Heart Failure in a Murine Dilated Cardiomyopathy Model
por: Ikeda, Masataka, et al.
Publicado: (2022)

Immune Modulating Effects of NKT Cells in a Physiologically Low Dose Leishmania major Infection Model after αGalCer Analog PBS57 Stimulation
por: Griewank, Klaus G., et al.
Publicado: (2014)

Crystal Structures of Bovine CD1d Reveal Altered αGalCer Presentation and a Restricted A’ Pocket Unable to Bind Long-Chain Glycolipids
por: Wang, Jing, et al.
Publicado: (2012)

A Designed α‐GalCer Analog Promotes Considerable Th1 Cytokine Response by Activating the CD1d‐iNKT Axis and CD11b‐Positive Monocytes/Macrophages
por: Ma, Juan, et al.
Publicado: (2020)

Repeated α-GalCer Administration Induces a Type 2 Cytokine-Biased iNKT Cell Response and Exacerbates Atopic Skin Inflammation in Vα14(Tg) NC/Nga Mice
por: Park, Hyun Jung, et al.
Publicado: (2021)

Targeting Immunosuppressive Tumor-Associated Macrophages Using Innate T Cells for Enhanced Antitumor Reactivity
por: Li, Yan-Ruide, et al.
Publicado: (2022)

Antitumor Responses of Invariant Natural Killer T Cells
por: Altman, Jennie B., et al.
Publicado: (2015)

A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II–IIIA non-small cell lung cancer: study protocol for a randomized controlled trial
por: Saka, Hideo, et al.
Publicado: (2017)

Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapy
por: Chen, Yuning, et al.
Publicado: (2023)

Charting a killer course to the solid tumor: strategies to recruit and activate NK cells in the tumor microenvironment
por: Portillo, Ana L., et al.
Publicado: (2023)

An Ex Vivo 3D Tumor Microenvironment-Mimicry Culture to Study TAM Modulation of Cancer Immunotherapy
por: Li, Yan-Ruide, et al.
Publicado: (2022)

Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention
por: Li, Yan-Ruide, et al.
Publicado: (2022)

Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies
por: Li, Yan-Ruide, et al.
Publicado: (2023)

Target tumor microenvironment by innate T cells
por: Li, Yan-Ruide, et al.
Publicado: (2022)

The Yin and Yang of Invariant Natural Killer T Cells in Tumor Immunity—Suppression of Tumor Immunity in the Intestine
por: Wang, Ying, et al.
Publicado: (2018)

Comparative Effectiveness Research (CER): A Summary of AHRQ’s CER on Therapies for Rheumatoid Arthritis
por: Oderda, Gary M., et al.
Publicado: (2011)

Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
por: Pilones, Karsten A., et al.
Publicado: (2012)

The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses
por: Pachynski, Russell K., et al.
Publicado: (2012)

Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity
por: Huang, Jianmei, et al.
Publicado: (2022)

Implementing CER: What Will It Take?
por: Biskupiak, Joseph E., et al.
Publicado: (2012)

Graft-versus-Host Disease Modulation by Innate T Cells
por: Fang, Ying, et al.
Publicado: (2023)

Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors
por: Chen, Ziqing, et al.
Publicado: (2019)

CerS1 but Not CerS5 Gene Silencing, Improves Insulin Sensitivity and Glucose Uptake in Skeletal Muscle
por: Błachnio-Zabielska, Agnieszka U., et al.
Publicado: (2022)

Conversion of Tumors into Autologous Vaccines by Intratumoral Injection of α-Gal Glycolipids that Induce Anti-Gal/α-Gal Epitope Interaction
por: Galili, Uri
Publicado: (2011)

Cytokine Induced Killer Cells as Promising Immunotherapy for Solid Tumors
por: Sangiolo, Dario
Publicado: (2011)

Evaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors
por: Li, Xiao-Dong, et al.
Publicado: (2014)

Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity
por: Schrand, Brett, et al.
Publicado: (2018)

Invariant natural killer T cells regulate anti-tumor immunity by controlling the population of dendritic cells in tumor and draining lymph nodes
por: Pilones, Karsten A, et al.
Publicado: (2014)

Patient engagement – the PaCER model
por: Hylton, Chris
Publicado: (2015)

Non-clinical development of CER-001
por: Barbaras, Ronald
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8u5al53fjdicasis1ngkkju28i